Axon Enterprise (AXON)
(Delayed Data from NSDQ)
$431.71 USD
+5.87 (1.38%)
Updated Nov 4, 2024 03:59 PM ET
After-Market: $431.57 -0.14 (-0.03%) 4:22 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$431.71 USD
+5.87 (1.38%)
Updated Nov 4, 2024 03:59 PM ET
After-Market: $431.57 -0.14 (-0.03%) 4:22 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Zacks News
Company News for Nov 10, 2022
by Zacks Equity Research
Companies In The News Are: AKAM, AXON, GMED, SRC.
Axon Enterprise (AXON) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Axon (AXON) delivered earnings and revenue surprises of 30.43% and 12.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Should You Invest in the SPDR S&P Aerospace & Defense ETF (XAR)?
by Zacks Equity Research
Sector ETF report for XAR
VERRA MOBILITY CORP (VRRM) Matches Q3 Earnings Estimates
by Zacks Equity Research
VERRA MOBILITY CORP (VRRM) delivered earnings and revenue surprises of 0% and 1.03%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Take the Zacks Approach to Beat the Market: Caterpillar, Amgen, Inventiva in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Axon (AXON) Stock Jumps 5.6%: Will It Continue to Soar?
by Zacks Equity Research
Axon (AXON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Take the Zacks Approach to Beat the Market: Automatic Data Processing, Fiserv, Deere in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Is SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XAR
Take the Zacks Approach to Beat the Market: Uber, Starbucks, Livent, Carter Bankshares in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Wall Street Analysts Predict a 27% Upside in Axon (AXON): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in Axon (AXON). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks Industry Outlook Highlights Axon Enterprise, MSA Safety, Brady and Intellicheck
by Zacks Equity Research
Axon Enterprise, MSA Safety, Brady and Intellicheck are part of Zacks Industry Outlook article.
Axon Enterprise (AXON) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Axon (AXON) delivered earnings and revenue surprises of 15.79% and 10.65%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
4 Stocks to Buy From the Thriving Security and Safety Services Industry
by Eshani Haque
Strong demand for Internet security products and enhanced digitalization bode well for the Zacks Security and Safety Services industry's near-term prospects. AXON, MSA, BRC and IDN are poised to benefit from this buoyancy.
Johnson Controls (JCI) Beats on Q3 Earnings, Revises FY'22 View
by Zacks Equity Research
Johnson Controls (JCI) sees growth in top and bottom lines in the third quarter. It modifies its existing guidance for full-year 2022.
Johnson Controls (JCI) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Johnson Controls (JCI) delivered earnings and revenue surprises of 1.19% and 1.69%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Axon Enterprise (AXON) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Axon (AXON) delivered earnings and revenue surprises of 80% and 11.04%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ADT (ADT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
ADT (ADT) delivered earnings and revenue surprises of -108.33% and 1.37%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Resideo Technologies (REZI) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Resideo Technologies (REZI) delivered earnings and revenue surprises of 38.10% and 3.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Acco Brands (ACCO) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Acco (ACCO) delivered earnings and revenue surprises of 22.22% and 5.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Axon Enterprise (AXON) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Axon (AXON) delivered earnings and revenue surprises of 187.50% and 7.84%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Axon Enterprise (AXON) Q4 Earnings Expected to Decline
by Zacks Equity Research
Axon (AXON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Applied DNA Sciences (APDN) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -231.58% and 2.62%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Axon Enterprise (AXON) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Axon (AXON) delivered earnings and revenue surprises of 333.33% and 18.55%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Axon Enterprise (AXON) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Axon (AXON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Invest in the SPDR S&P Aerospace & Defense ETF (XAR)?
by Zacks Equity Research
Sector ETF report for XAR